Company: BIAF
Filing Date: 2025-08-14
Form Type: 8-K
Source: 0001641172-25-024172
Chunk: 6

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-14
Form: 8-K
Item: Item 5.03
Chunk 6
---
Item
5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On
August 13, 2025, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation (the “ Certificate
of Amendment”) to increase the number of authorized shares of the Company’s Common Stock from 100,000,000 to 350,000,000.
The Certificate of Amendment was approved by the Company’s stockholders at the Company’s Annual Meeting of Stockholders held
on July 25, 2025, as reported in the Company’s Current Report on Form 8-K filed with the SEC on July 25, 2025.

In
connection with the Private Placement, on August 13, 2025, the Company filed a Certificate of Designations, Preferences and Rights of
the Series B Preferred Stock (the “ Certificate of Designations”) with the Secretary of State of the State of Delaware. The
Series B Preferred Stock have the following rights, preferences, powers, privileges and restrictions, qualifications and limitations.

Dividends

Voting

Conversion

Limitations
on Conversion

Compliance
with Rules of Principal Market

Adjustment
Upon Issuance of Common Stock

The
foregoing descriptions of the Certificate of Amendment and the Certificate of Designations are not complete and are qualified in their
entirety by reference to the full text of the Certificate of Amendment and the Certificate of Designations, copies of which are filed
as Exhibit 3.1 and Exhibit 3.2, respectively to this Current Report on Form 8-K and are hereby incorporated by reference.

Item
8.01 Other Events.